Clinical Trial Update: Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating concomitant ultrfractionated brain irradiation with temozolomide for inoperable primary glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED